Defining the clinical utility of PSMA-targeted PET imaging of prostate cancer

Research output: Contribution to journalEditorial

Original languageEnglish (US)
Pages (from-to)160-161
Number of pages2
JournalBJU International
Volume120
Issue number2
DOIs
StatePublished - Aug 1 2017

Fingerprint

Prostatic Neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

@article{ee4c7fe667194e32b46346f110635fb2,
title = "Defining the clinical utility of PSMA-targeted PET imaging of prostate cancer",
author = "Michael Gorin and Pomper, {Martin Gilbert} and Kenneth Pienta and Steven Rowe",
year = "2017",
month = "8",
day = "1",
doi = "10.1111/bju.13801",
language = "English (US)",
volume = "120",
pages = "160--161",
journal = "BJU International",
issn = "1464-4096",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Defining the clinical utility of PSMA-targeted PET imaging of prostate cancer

AU - Gorin, Michael

AU - Pomper, Martin Gilbert

AU - Pienta, Kenneth

AU - Rowe, Steven

PY - 2017/8/1

Y1 - 2017/8/1

UR - http://www.scopus.com/inward/record.url?scp=85024400675&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024400675&partnerID=8YFLogxK

U2 - 10.1111/bju.13801

DO - 10.1111/bju.13801

M3 - Editorial

VL - 120

SP - 160

EP - 161

JO - BJU International

JF - BJU International

SN - 1464-4096

IS - 2

ER -